NCT02619825

Brief Summary

First, investigators must determine the physiological standards across age classes of myocardial stiffness estimated by Elastography in ultrafast (estimated right ventricular stiffness \[VD\] and left ventricular \[LV\]). This will be done in groups of children without heart condition, age group (10 children per group, four age groups \[0-1mois, 1 month-1 year 1 year-5 years, 5 years-15years\]). Secondly, investigators will evaluate myocardial stiffness Elastography (RV and LV) on different groups of children (same age group) with cardiomyopathy and examine correlations with the conventional parameters of systolic and diastolic function of both ventricles and with myocardial strain values. The total population of the study will be 120 children (40 healthy, 80 patients).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 23, 2015

Completed
9 days until next milestone

Study Start

First participant enrolled

November 1, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 2, 2015

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

November 6, 2017

Status Verified

October 1, 2017

Enrollment Period

1.5 years

First QC Date

October 23, 2015

Last Update Submit

October 31, 2017

Conditions

Keywords

Child

Outcome Measures

Primary Outcomes (1)

  • Myocardial diastolic stiffness UltrafastEcho (kPa)

    Normal values and intra-observer variability and inter-observer variability to demonstrate that the Aixplorer® myocardial elastography provides a reproducible assessment of myocardial stiffness.

    through study completion, an average of 1 year

Study Arms (3)

Group 1 "healthy volunteers

OTHER

Echography and Elastography To determine physiological standards across age classes of myocardial stiffness estimated by Elastography in ultrafast (estimated right ventricular stiffness \[VD\] and left ventricular \[LV\]). This will be done in groups of children without heart condition, age group (10 children per group, four age groups \[0-1mois, 1 month-1 year 1 year-5 years, 5 years-15years\]).

Device: EchographyDevice: Elastography

Group 2 Patients CMH primitive

OTHER

Echography and Elastography To evaluate myocardial stiffness Elastography (RV and LV) on different groups of children (same age group) with Hypertrophic Cardiomyopathy (HCM) non obstructive primitive and examine correlations with the conventional parameters of systolic and diastolic function of both ventricles and with myocardial strain values.

Device: EchographyDevice: Elastography

Group 3 Patients primitive CMD:

OTHER

Echography and Elastography To evaluate myocardial stiffness Elastography (RV and LV) on different groups of children (same age group) with Dilated Cardiomyopathy primitive and examine correlations with the conventional parameters of systolic and diastolic function of both ventricles and with myocardial strain values.

Device: EchographyDevice: Elastography

Interventions

cardiac ultrasound, in two stages, with an estimate of the stiffness of the myocardium ShearWave Elastography (Aixplorer®) and measurement of all echocardiographic parameters estimated in children with a clinical ultrasound Machine

Group 1 "healthy volunteersGroup 2 Patients CMH primitiveGroup 3 Patients primitive CMD:

cardiac ultrasound, in two stages, with an estimate of the stiffness of the myocardium ShearWave Elastography (Aixplorer®) and

Group 1 "healthy volunteersGroup 2 Patients CMH primitiveGroup 3 Patients primitive CMD:

Eligibility Criteria

Age1 Day - 15 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Group 1. Healthy Age criteria met by group \[0-1mois, 1 month-1 year 1 year-5 years, 5 years-15years\]
  • consultation for heart murmur
  • Recipient of a social protection scheme or entitled (excluding AME)
  • Signed informed consent by the holders of parental authority
  • Group 2. Patients MHC nonobstructive:
  • Age criteria met by group \[1 month-1 year 1 year-5 years\]
  • Diagnostic criteria of non-obstructive HCM validated by the medical team of pediatric cardiology center (Necker)
  • Recipient of a social protection scheme or entitled (excluding AME)
  • Signed informed consent by the holders of parental authority
  • Group 3. Patients primitive CMD:
  • Age criteria met by group \[1 month-1 year 1 year-5 years\]
  • Diagnostic criteria of primary CMD validated by the medical team of pediatric cardiology center (Necker)
  • Recipient of a social protection scheme or entitled (excluding AME)
  • Signed informed consent

You may not qualify if:

  • Group 1. Healthy Patients:
  • Age\> 15 years
  • Heart and Systemic Pathology identified
  • metabolic and tissue pathology.
  • known genetic pathology may have cardiac involvement.
  • No echogenicity,
  • Allergy echocardiography gel.
  • Group 2. Group CMH primitive Patients
  • No echogenicity,,
  • Allergy echocardiography gel.
  • Arrhythmia.
  • Pacemaker or defibrillator
  • Group 3. Patients primitive CMD:
  • No echogenicity,,
  • Allergy echocardiography gel.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Necker

Paris, 75005, France

Location

MeSH Terms

Conditions

Cardiomyopathy, DilatedCardiomyopathy, Hypertrophic

Interventions

UltrasonographyElasticity Imaging Techniques

Condition Hierarchy (Ancestors)

CardiomegalyHeart DiseasesCardiovascular DiseasesCardiomyopathiesLaminopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesAortic Stenosis, SubvalvularAortic Valve StenosisAortic Valve DiseaseHeart Valve Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Olivier VILLEMAIN, MD

    LAngevin Institute

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2015

First Posted

December 2, 2015

Study Start

November 1, 2015

Primary Completion

May 1, 2017

Study Completion

July 1, 2017

Last Updated

November 6, 2017

Record last verified: 2017-10

Locations